The overexpression of LPCAT1 mRNA was associated with multiple disorders, including hepatocellular carcinoma [30], endometrial cancer [31], pulmonary emphysema [65], lung carcinoma [66], epithelioid trophoblastic tumors [67], and breast carcinoma [26]. This evidence concerns the gene LPCAT1 and breast carcinoma.